Funds › Empery Asset Management, LP
Empery Asset Management, LP
13F for Q2 2026, filed Aug 11, 2026. 32 positions worth $86.5M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Empery Asset Management, LP in the latest 13F quarter?
Using 13F.ai, how has Empery Asset Management, LP's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Empery Asset Management, LP's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q2 2026
Largest first. Common shares only.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | XFOR X4 Pharmaceuticals, Inc. | 6.93M | $32.4M | 37.4% | -22.5% | 13F ↗ |
| 2 | EMPD Empery Digital Inc. | 2.93M | $10.4M | 12.1% | Unchanged | 13F ↗ |
| 3 | NGEN NervGen Pharma Corp. | 4.00M | $8.2M | 9.5% | New | 13F ↗ |
| 4 | DTIL Precision BioSciences, Inc. | 776,093 | $6.1M | 7.1% | -60.6% | 13F ↗ |
| 5 | CLNN Clene Inc. | 916,532 | $5.6M | 6.5% | New | 13F ↗ |
| 6 | ANVS Annovis Bio, Inc. | 2.40M | $4.5M | 5.2% | New | 13F ↗ |
| 7 | LTRN Lantern Pharma Inc. | 842,669 | $3.5M | 4.1% | New | 13F ↗ |
| 8 | AMC AMC Entertainment Holdings, Inc. | 1.71M | $3.3M | 3.8% | New | 13F ↗ |
| 9 | TNYA Tenaya Therapeutics, Inc. | 3.86M | $2.9M | 3.3% | -9.9% | 13F ↗ |
| 10 | YDDL One and One Green Technologies. INC | 761,706 | $1.5M | 1.8% | New | 13F ↗ |
| 11 | CYN Cyngn Inc. | 927,059 | $1.3M | 1.5% | -3.2% | 13F ↗ |
| 12 | VENU Venu Holding Corporation | 512,818 | $1.2M | 1.3% | -49.1% | 13F ↗ |
| 13 | GLNDW Greenland Energy Company · Spac Combination | 1.00M | $850.0K | 1.0% | New | 13F ↗ |
| 14 | URG Ur Energy Inc | 620,136 | $843.4K | 1.0% | Unchanged | 13F ↗ |
| 15 | MSLE Satellos Bioscience Inc. | 107,100 | $832.7K | 1.0% | -53.5% | 13F ↗ |
| 16 | JAGU Jaguar Uranium Corp. | 487,500 | $814.1K | 0.9% | Unchanged | 13F ↗ |
| 17 | CLRB Cellectar Biosciences, Inc. | 189,605 | $527.1K | 0.6% | New | 13F ↗ |
| 18 | SCYX SCYNEXIS, Inc. | 126,451 | $514.7K | 0.6% | New | 13F ↗ |
| 19 | RNTX Rein Therapeutics, Inc. | 370,834 | $385.7K | 0.4% | New | 13F ↗ |
| 20 | BTCT BTC Digital Ltd. | 350,877 | $288.9K | 0.3% | New | 13F ↗ |
| 21 | BCTXL BriaCell Therapeutics Corp. · *W Exp 01/15/203 | 300,000 | $267.0K | 0.3% | Unchanged | 13F ↗ |
| 22 | MTEKW Maris-Tech Ltd. · *W Exp 02/04/202 | 297,600 | $58.0K | 0.1% | Unchanged | 13F ↗ |
| 23 | PRZO ParaZero Technologies Ltd. | 113,771 | $55.3K | 0.1% | -59.7% | 13F ↗ |
| 24 | DUKRW DUKE Robotics Corp. · *W Exp 05/06/203 | 35,000 | $45.1K | 0.1% | New | 13F ↗ |
| 25 | Nutriband Inc *W Exp 99/99/999 | 40,218 | $40.2K | <0.1% | Unchanged | 13F ↗ |
| 26 | RTACW Renatus Tactical Acquisition Corp I Warrants · Warrants | 50,000 | $38.0K | <0.1% | Unchanged | 13F ↗ |
| 27 | MDAIW Spectral AI, Inc. · Spac Combination | 33,336 | $18.5K | <0.1% | Unchanged | 13F ↗ |
| 28 | NEXRW Nexera Technologies Ltd · *W Exp 08/26/202 | 360,577 | $10.4K | <0.1% | Unchanged | 13F ↗ |
| 29 | BNCWW BNB Standard Corporation · *W Exp 02/11/202 | 500,000 | $9,250 | <0.1% | Unchanged | 13F ↗ |
| 30 | FGIWW FGI Industries Ltd. · *W Exp 99/99/999 | 83,928 | $7,973 | <0.1% | Unchanged | 13F ↗ |
| 31 | NRSNW NeuroSense Therapeutics Ltd. · *W Exp 11/10/202 | 100,402 | $6,325 | <0.1% | Unchanged | 13F ↗ |
| 32 | NXGLW NexGel, Inc · *W Exp 12/27/202 | 90,000 | $3,474 | <0.1% | Unchanged | 13F ↗ |
Changes since Q1 2026
12 new, 0 added to, 7 trimmed, 12 exited, 13 unchanged. By estimated dollars.
New positions (12)
| NGEN NervGen Pharma Corp. | 4.00M | New | $8.2M |
| CLNN Clene Inc. | 916,532 | New | $5.6M |
| ANVS Annovis Bio, Inc. | 2.40M | New | $4.5M |
| LTRN Lantern Pharma Inc. | 842,669 | New | $3.5M |
| AMC AMC Entertainment Holdings, Inc. | 1.71M | New | $3.3M |
| YDDL One and One Green Technologies. INC | 761,706 | New | $1.5M |
| GLNDW Greenland Energy Company · Spac Combination | 1.00M | New | $850.0K |
| CLRB Cellectar Biosciences, Inc. | 189,605 | New | $527.1K |
| SCYX SCYNEXIS, Inc. | 126,451 | New | $514.7K |
| RNTX Rein Therapeutics, Inc. | 370,834 | New | $385.7K |
Added to (0)
None this quarter.
Trimmed (7)
| XFOR X4 Pharmaceuticals, Inc. | 6.93M | -22.5% | -$9.4M |
| DTIL Precision BioSciences, Inc. | 776,093 | -60.6% | -$9.4M |
| VENU Venu Holding Corporation | 512,818 | -49.1% | -$1.1M |
| MSLE Satellos Bioscience Inc. | 107,100 | -53.5% | -$956.3K |
| TNYA Tenaya Therapeutics, Inc. | 3.86M | -9.9% | -$313.2K |
| PRZO ParaZero Technologies Ltd. | 113,771 | -59.7% | -$81.9K |
| CYN Cyngn Inc. | 927,059 | -3.2% | -$42.7K |
Exited (12)
| IMPP Imperial Petroleum Inc. | 877,645 | Exited | -$3.8M |
| BSIN Big Sky Industrial Inc. | 1.92M | Exited | -$1.7M |
| Scynexis Inc | 1.85M | Exited | -$1.7M |
| CRML Critical Metals Corp. · Pubco Ord Shs | 132,039 | Exited | -$1.0M |
| PMN ProMIS Neurosciences Inc. | 60,353 | Exited | -$766.5K |
| SLE Super League Enterprise, Inc. | 132,917 | Exited | -$491.8K |
| TLPH Talphera, Inc. | 590,481 | Exited | -$441.0K |
| BNTC Benitec Biopharma Inc. | 30,440 | Exited | -$324.2K |
| ABTS Abits Group Inc | 172,761 | Exited | -$266.1K |
| NSRX Nasus Pharma Ltd. | 45,803 | Exited | -$101.7K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q2 2026.
Filings
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer